» Articles » PMID: 34235281

Biological Characteristics of a Sub-population of Cancer Stem Cells from Two Triple-negative Breast Tumour Cell Lines

Overview
Journal Heliyon
Specialty Social Sciences
Date 2021 Jul 8
PMID 34235281
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Triple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a homogeneous cell population. The objective of this work was to determine differences in ultrastructural morphology, proliferative capacity, and mouse-xenotransplantation characteristics of the MDA-MB-231 and MDA-MB-436 TNBT cell lines with the CD44 /CD24 phenotype in order to study their exosomes. The results show that the CD44 /CD24 MBA-MB-231 cells had a population doubling time of 41.56 h, compared to 44.79 h in the MDA-MB-436 cell line. After magnetic immunoseparation, 18.75% and 14.56% of the stem cell population of the MDA-MB-231 and MDA-MB-436 cell lines, respectively, were of the CD44 /CD24 phenotype, which were expanded to reach purities of 80.4% and 87.6%. The same expanded lineage in both cell lines was shown to possess the pluripotency markers Nanog and Oct4. Under a scanning electron microscope, the CD44 /CD24 lineage of the MBA-MD-231 cell line formed groups of more interconnected cells than this lineage of the MBA-MD-436 line. A total of 16% of the mice inoculated with the CD44 /CD24 lineage of either cell line presented tumours of the breast, lung, and submandibular ganglia, in whose tissues variable numbers of inoculated cells were found 30 days post-inoculation. By magnetic immunoselection, it was possible to isolate in similar quantities and characterize, expand, and xenotransplant the CD44 /CD24 lineage of the MDA-MB-231 and MDA-MB-436 cell lines. The former cell line has greater proliferative capacity, the two lines differ under scanning electron microscopy in how they intercommunicate, and both cell lines induce new tumours in mice and persist at least 30 days post-inoculation in the transplanted animal so their exosomes would also be different.

Citing Articles

Computational identification of surface markers for isolating distinct subpopulations from heterogeneous cancer cell populations.

Gardner A, Jost T, Morgan D, Brock A NPJ Syst Biol Appl. 2024; 10(1):120.

PMID: 39420005 PMC: 11487074. DOI: 10.1038/s41540-024-00441-6.


High BMI Is Associated with Changes in Peritumor Breast Adipose Tissue That Increase the Invasive Activity of Triple-Negative Breast Cancer Cells.

Miracle C, McCallister C, Denning K, Russell R, Allen J, Lawrence L Int J Mol Sci. 2024; 25(19).

PMID: 39408921 PMC: 11476838. DOI: 10.3390/ijms251910592.


Green Tea Leaves and Rosemary Extracts Selectively Induce Cell Death in Triple-Negative Breast Cancer Cells and Cancer Stem Cells and Enhance the Efficacy of Common Chemotherapeutics.

Raad C, Raad A, Pandey S Evid Based Complement Alternat Med. 2024; 2024:9458716.

PMID: 39376573 PMC: 11458307. DOI: 10.1155/2024/9458716.


Flow cytometry-based quantitative analysis of cellular protein expression in apoptosis subpopulations: A protocol.

Alshehade S, Almoustafa H, Alshawsh M, Chik Z Heliyon. 2024; 10(13):e33665.

PMID: 39040270 PMC: 11260931. DOI: 10.1016/j.heliyon.2024.e33665.


The in vitro dynamics of pseudo-vascular network formation.

Oraiopoulou M, Couturier D, Bunce E, Cannell I, Sweeney P, Naylor H Br J Cancer. 2024; 131(3):457-467.

PMID: 38902534 PMC: 11300916. DOI: 10.1038/s41416-024-02722-7.


References
1.
Youn B, Sen A, Behie L, Girgis-Gabardo A, Hassell J . Scale-up of breast cancer stem cell aggregate cultures to suspension bioreactors. Biotechnol Prog. 2006; 22(3):801-10. DOI: 10.1021/bp050430z. View

2.
Guo L, Xu D, Lu Y, Peng J, Jiang L . Detection of circulating tumor cells by reverse transcription‑quantitative polymerase chain reaction and magnetic activated cell sorting in the peripheral blood of patients with hepatocellular carcinoma. Mol Med Rep. 2017; 16(5):5894-5900. PMC: 5865766. DOI: 10.3892/mmr.2017.7372. View

3.
Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S, Clarke M . Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(7):3983-8. PMC: 153034. DOI: 10.1073/pnas.0530291100. View

4.
Palomeras S, Ruiz-Martinez S, Puig T . Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance. Molecules. 2018; 23(9). PMC: 6225226. DOI: 10.3390/molecules23092193. View

5.
Cocco S, Piezzo M, Calabrese A, Cianniello D, Caputo R, Lauro V . Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives. Int J Mol Sci. 2020; 21(13). PMC: 7369987. DOI: 10.3390/ijms21134579. View